HMPV: Current Situation and Control Solutions

Currently, the rising number of human metapneumovirus (HMPV) infections is causing alarm in many countries around the world. With its ability to spread widely in winter and early spring, HMPV has become a major challenge in the detection and control of respiratory diseases. To address this problem, the use of advanced technologies such as the ARVI Screen Real-TM kit from Sacace Biotechnology has opened up a breakthrough solution, enabling accurate detection and differentiation of many different viruses. This is an important step forward in optimizing expected outcomes and controlling epidemics.

Current Situation

- Rising infections: The number of HMPV infections is increasing in many regions, such as China and India.

- Close monitoring: Health authorities are monitoring the situation closely due to the potential for a high number of hospitalizations.

- Not a pandemic: At present, HMPV is not considered a pandemic threat.

- Outbreak season: HMPV outbreaks typically occur in winter and early spring.

- Global impact: The outbreak in China has caused concern worldwide.

Figure 1: Statistical chart of the causative agents of acute respiratory infections in children in Ho Chi Minh City at two time points

Controlling HMPV - Necessary but Not ⁠Easy

- Respiratory viruses often cause similar symptoms, making them very difficult to distinguish

- Real-time PCR is the method recommended by WHO for detecting HMPV

- A solution is needed to differentiate HMPV from other respiratory viruses in order to control the epidemic situation.

The ARVI Screen Real-TM Solution

ARVI Screen Real-TM is a multi-pathogen detection test kit developed by Sacace Biotechnologies, designed to detect and differentiate 7 different groups of respiratory viruses, including:

1. 1. hRSV RNA (respiratory syncytial virus)
2. 2. hMPV RNA
3. 3. hPIV RNA (Parainfluenza virus types 1-4)
4. 4. hCoV RNA (human Coronavirus strains: OC43, E229, NL63, HKU1)
5. 5. hRV RNA (Rhinovirus)
6. 6. hADV DNA (Adenovirus types B, C, E)
7. 7. hBOV DNA (Bocavirus)

Some advantages of using ARVI Screen Real-TM (Sacace)

• - Detection and differentiation of multiple pathogens: significantly reduces the time and resources needed for diagnosis, ensuring effective epidemic control.
• - High sensitivity and specificity: The kit is designed to deliver accurate results, minimizing false-positive and false-negative cases.
• - Easy-to-use procedure: The testing procedure is simple and can be quickly implemented in clinical settings.
• - Rapid results: Results can be returned in a short time, providing timely support for clinical decisions.

Prevention and Treatment

• - No vaccine yet: There is currently no vaccine to prevent HMPV.
• - Preventive measures: Wash hands frequently and avoid close contact with sick people.
• - Symptomatic treatment: Use pain relievers and decongestants to manage symptoms.
• - Medical intervention: Severe cases require medical intervention and hospitalization for treatment.
• - No antibiotics: Antibiotics are not effective in treating HMPV unless there is a secondary bacterial infection.

Conclusion

The ARVI Screen Real-TM kit represents an important step forward in the rapid diagnosis of respiratory viral infections, including hMPV. As understanding of hMPV continues to grow, tools such as ARVI Screen Real-TM will play an important role in the effective management of respiratory diseases.

Viet Huy - A Partner to Vietnamese Healthcare for Nearly 20 Years

For nearly 20 years, Viet Huy has been a familiar name to healthcare facilities nationwide in the field of molecular diagnostics. Beyond supplying high-quality products, Viet Huy is dedicated to supporting its partners, from in-depth training to comprehensive technical services, helping to optimize operations and improve testing quality.

We always aim to create outstanding value, accompanying our customers on the journey to deliver the best healthcare services to the community.

Viet Huy - Leading in Technology, Joining Hands for Public Health